Literature DB >> 24602901

Synthesis of a new fluorine-18-labeled bexarotene analogue for PET imaging of retinoid X receptor.

Min Wang1, Toni Davis1, Mingzhang Gao1, Qi-Huang Zheng2.   

Abstract

The reference standard 2-fluoro-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid was synthesized from 2,5-dimethyl-2,5-hexanediol and 2-fluoro-4-methylbenzoic acid in 10 steps with 3% overall chemical yield. The precursor 2-nitro-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid was synthesized from 2,5-dimethyl-2,5-hexanediol and dimethyl-2-nitroterephthalate in seven steps with 2% overall chemical yield. The target tracer 2-[(18)F]fluoro-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid was synthesized from its nitro-precursor by the nucleophilic substitution with K[(18)F]F/Kryptofix 2.2.2 and isolated by HPLC combined with solid-phase extraction (SPE) purification in 20-30% radiochemical yield with 37-370GBq/μmol specific activity at end of bombardment (EOB).
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  2-[(18)F]fluoro-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid; Alzheimer’s disease (AD); Apolipoprotein E (APOE); Bexarotene; Cancer; Positron emission tomography (PET); Retinoid X receptor (RXR)

Mesh:

Substances:

Year:  2014        PMID: 24602901     DOI: 10.1016/j.bmcl.2014.02.037

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Preclinical PET Neuroimaging of [11C]Bexarotene.

Authors:  Benjamin H Rotstein; Michael S Placzek; Hema S Krishnan; Aleksandra Pekošak; Thomas Lee Collier; Changning Wang; Steven H Liang; Ethan S Burstein; Jacob M Hooker; Neil Vasdev
Journal:  Mol Imaging       Date:  2016-08-23       Impact factor: 4.488

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.